APA (7th ed.) Citation

Alana Aragón-Herrera, Alana Aragón-Herrera, Manuel Otero-Santiago, Laura Anido-Varela, Sandra Moraña-Fernández, Manuel Campos-Toimil, . . . Francisca Lago. (2022). The Treatment With the SGLT2 Inhibitor Empagliflozin Modifies the Hepatic Metabolome of Male Zucker Diabetic Fatty Rats Towards a Protective Profile. Frontiers Media S.A..

Chicago Style (17th ed.) Citation

Alana Aragón-Herrera, et al. The Treatment With the SGLT2 Inhibitor Empagliflozin Modifies the Hepatic Metabolome of Male Zucker Diabetic Fatty Rats Towards a Protective Profile. Frontiers Media S.A., 2022.

MLA (9th ed.) Citation

Alana Aragón-Herrera, et al. The Treatment With the SGLT2 Inhibitor Empagliflozin Modifies the Hepatic Metabolome of Male Zucker Diabetic Fatty Rats Towards a Protective Profile. Frontiers Media S.A., 2022.